116 related articles for article (PubMed ID: 3424287)
1. Heparin cofactor II: a simple assay method and results of its clinical application.
Vinazzer H; Pangraz U
Thromb Res; 1987 Oct; 48(2):153-60. PubMed ID: 3424287
[TBL] [Abstract][Full Text] [Related]
2. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
Hortin GL; Tollefsen DM; Santoro SA
Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
[TBL] [Abstract][Full Text] [Related]
3. Heparin cofactor II assay. Elimination of heparin and antithrombin-III effects.
Nakhleh R; Vogt JM; Edson JR
Am J Clin Pathol; 1988 Mar; 89(3):353-8. PubMed ID: 3348170
[TBL] [Abstract][Full Text] [Related]
4. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
5. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
Shimotori T; Sakuragawa N
Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
[TBL] [Abstract][Full Text] [Related]
7. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
Dupouy D; Sié P; Dol F; Boneu B
Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
[TBL] [Abstract][Full Text] [Related]
8. Influence of heparin cofactor II (HCII) on the determination of antithrombin III (AT).
Tran TH; Duckert F
Thromb Res; 1985 Nov; 40(4):571-6. PubMed ID: 3841235
[No Abstract] [Full Text] [Related]
9. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
Andersson TR
Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
[TBL] [Abstract][Full Text] [Related]
10. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
Tran TH; Zbinden B; Lämmle B; Duckert F
Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
Carson L; Doctor VM
Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
[TBL] [Abstract][Full Text] [Related]
12. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombin III and heparin cofactor II].
Kondo S; Niwa M
Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
[No Abstract] [Full Text] [Related]
14. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
15. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.
Scully MF; Ellis V; Kakkar VV
Thromb Res; 1986 Feb; 41(4):489-99. PubMed ID: 2421433
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues.
Jeske W; Fareed J
Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268
[TBL] [Abstract][Full Text] [Related]
17. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
18. Turnover study of heparin cofactor II in healthy man.
Sié P; Dupouy D; Pichon J; Boneu B
Thromb Haemost; 1985 Oct; 54(3):635-8. PubMed ID: 3841420
[TBL] [Abstract][Full Text] [Related]
19. Heparin cofactor II: experimental approach to a new assay and clinical results.
Vinazzer H; Stocker K
Thromb Res; 1991 Feb; 61(3):235-41. PubMed ID: 2028443
[TBL] [Abstract][Full Text] [Related]
20. Heparin cofactor II-dependent antithrombin activity of calcium spirulan.
Hayakawa Y; Hayashi T; Hayashi K; Hayashi T; Ozawa T; Niiya K; Sakuragawa N
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):554-60. PubMed ID: 8874866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]